Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Natural raises $30M to reinvent payments for AI agents — and take on Stripe
The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.
Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation
The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.
Why Greylock capped its new fund at $1.5B when it says it could have raised more
By keeping the number of investments to about 25 per fund, Greylock aims to remain what it calls “the most important partner” to its founders.
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
Oratomic raises $300M to build a viable quantum computer that needs only 20K qubits
The massive round was co-led by ARCH Venture Partners, Spark Capital, and Khosla Ventures.
Lovable reportedly in talks to double its valuation to $13.2B
The $300 million round is expected to be led by Menlo Ventures, Sifted reported.
Prime Intellect raises $130M Series A to help enterprises build their own AI agents
The round, led by Radical Ventures, values the two-year old startup at $1 billion.
These AI startups are growing revenue at faster and faster rates
There are a lot of fast-growing AI startups, but some are growing even faster, they say.